Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 45 for “"ADAMTS13"”.
-
Mechanism of ADAMTS13 regulation
Studies demonstrated ADAMTS13 possesses unique properties with a mystifying regulatory mechanism. ADAMTS13’s role is in its proteolytic function to its VWF. The disparity in the hemostatic balance between ADAMTS13 activity and the distribution of VWF multimers could result in the bleeding disorder …
-
Characterizing Protease-Resistant ADAMTS13 Mutants
ADAMTS13 is a metalloprotease that regulates the length, and thus, the platelet-capturing capacity of von Willebrand factor. The regulation of ADAMTS13 activity remains poorly understood. Numerous circulating proteases cleave ADAMTS13 in vitro, impairing its activity, but the physiological …
-
ADAMTS13 Activity in Dogs with Chronic Enteropathies
… with a thrombospondin type 1 motif, member 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving enzyme, and increased circulating vWF. The primary aim of this study is to assess plasma ADAMTS13 activity, vWF antigen (vWF:Ag) concentration, and vWF collagen binding activity (vWF:CBA) in dogs …
-
ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
… TTP is associated with the severe deficiency of ADAMTS13 (activity <10%), the metalloprotease responsible for the proteolytic regulation of VWF multimers size. In the acquired form of the disease, the severe deficiency of ADAMTS13 is caused by anti-ADAMTS13 antibodies that inhibit ADAMTS13 …
-
Development of an ADAMTS13-based Therapy for Thrombosis
Recombinant ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13)-based therapies were approved by the FDA to treat congenital thrombotic thrombocytopenic purpura (TTP), and preclinical studies have demonstrated its efficacy in mice. However, ADAMTS13 is …
-
Studies of ADAMTS13 expression and activity in the kidney
… and aggregation at sites of vascular injury. ADAMTS13 is the sole physiological VWF-cleaving protease, thus regulating the size of thrombus growth. Dysfunctional ADAMTS13 leads to thrombotic thrombocytopenic purpura (TTP), which is either due to mutations (congenital TTP) or auto-antibodies …
-
Unraveling the mechanism of ADAMTS13 resistance to protease inhibition
Background: ADAMTS13 is a metalloprotease that regulates the delicate balance between VWF multimeric length and its platelet capturing capacity. Unlike other ADAMTS and coagulation proteases, ADAMTS13 exhibits a prolonged half-life of several days as an active protease, suggesting that it is …
-
Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease
… cascade. vWF is cleaved by the metalloprotease ADAMTS13, regulating the multimers size, which hinders vWF’s ability to function properly. The three main types of vWD —Type I, II, and III— are not well defined, and as a result are all similarly treated with plasma-derived vWF replacement therapy. …
-
Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions
ADAMTS13 (A Disintegrin And Metalloprotease with ThromboSpondin type1 repeats-13) is an enzyme that is mainly synthesized in the liver and secreted into the blood stream. In plasma, ADAMTS13 cleaves ultra large (UL) von Willebrand factor (VWF) newly released from stimulated and/or injured …
-
Plasma ADAMTS13 activity in dogs with severe thrombocytopenia and presumed immune thrombocytopenia
Background: In humans, deficiency of plasma ADAMTS-13, a von Willebrand factor cleaving enzyme, is an important cause of thrombocytopenia in immune thrombotic thrombocytopenic purpura (iTTP). This disease can be difficult to differentiate from immune thrombocytopenia (ITP) in people. Further …
-
Ο ρόλος του άξονα vWF-ADAMTS13 στην παθοφυσιολογία της Δρεπανοκυτταρικής Νόσου. Τρέχουσες και μελλοντικές προοπτικές
… μοντέλα στρέφονται στην διόρθωση του άξονα ADAMTS13-vWF με στόχο την μειωμένη παραγωγή των μεγάλων πολυμερών σε μια προσπάθεια περιορισμού της εξέλιξης των επώδυνων κρίσεων. Τα αποτελέσματα ενισχύουν την άποψη ότι ο ενδοθηλιακός vWF συμβάλλει στην παθογένεση του αγγειοαποφρακτικού επεισοδίου …
-
Μελέτη των πολυμορφισμών του γονιδίου που κωδικοποιεί την πρωτεΐνη Adamts 13 σε έγκυες γυναίκες και συσχέτισή τους με την εμφάνιση προεκλαμψίας
… This study aimed to examine the involvement of ADAMTS13, von Willebrand, and the complement system in the pathogenesis of preeclampsia/HELLP syndrome. We studied 30 Caucasian preeclamptic pregnant women and a control group of 15 healthy pregnancies. Genetic sequencing of ADAMTS13 and complement …
-
The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype
… of the von Willebrand factor cleaving protease (ADAMTS13). Over 100 mutations have been identified in ADAMTS13 yet, in some cases, these mutations in congenital TTP alone do not explain the disease phenotype, particularly in late-onset congenital TTP. One aim of this study was to analyse the …
-
Διαταραχές αιμόστασης σε ασθενείς με καρδιακές αρρυθμίες, μελέτη του ενδοθηλίου, παράγοντας vWF, ADAMTS13, θρομβομοντουλίνης (TM), ιστικού παράγοντα (TF)
… όπως της δυσλειτουργίας του ενδοθηλίου, της ADAMTS13, του παράγοντα Von Willebrand, της θρομβομοντουλίνης και του ιστικού παράγοντα. Αυτή η εργασία ανασκόπησης συνοψίζει την τρέχουσα βιβλιογραφία σχετικά με τον ρόλο του ενδοθηλίου και αυτών των βιοδεικτών στις διαταραχές αιμόστασης σε …
-
The association of von Willebrand factor and its cleaving protease (ADAMTS13) with inflammation in young adults: the African-PREDICT study
MHS (Cardiovascular Physiology), North-West University, Potchefstroom Campus
-
The association of von Willebrand factor and its cleaving protease (ADAMTS13) with health behaviours in young black and white adults: the African-PREDICT study
… VIII from proteolysis. vWF is regulated by ADAMTS13 (A Disintegrin And Metalloproteinase with a ThromboSpondin type 1 motif, member 13) that cleaves vWF into smaller, less reactive molecules. Previous reports suggest that modifiable lifestyle factors such as physical activity, diet and …
-
Interaction Between the Metalloprotease ADAMTS-13 and the Proteins of the Alternative Pathway of the Complement System
… who can not cleave VWF multimers due to genetic ADAMTS13 deficiency, we investigated the mechanism through which VWF modulates complement, and its pathophysiological implications for human diseases. Using assays of ex-vivo serum-induced C3 and C5b-9 deposits on endothelial cells we documented …
-
The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance
… size of VWF. The VWF-specific metalloprotease ADAMTS13 decreases VWF multimer size by cleaving at Y1605-M1606 in the VWF A2 domain. This thesis examined the sensitivity of ADAMTS13 cleavage to mutagenesis of the full-length multimerized VWF substrate, and a small VWF A2 domain fragment, VWF115. …
-
PATHOPHYSIOLOGY OF VON WILLEBRAND FACTOR IN BLEEDING AND THROMBOSIS
… aimed to evaluate whether the reduction of ADAMTS13 activity or the alteration of ADAMTS13-VWF equilibrium may play a role in DVT pathogenesis. In Chapter 7, we performed a case-control study to evaluate the association between ADAMTS13, VWF, and FVIII plasma levels and DVT. We showed that a …
Page 1 of 3